Abstract:Incidence of liver cancer as one of the most common cancers worldwide and become the significant contributor for the mortality among cancer patients. The disease burden, risk factors, and trends in incidence and mortality of liver cancer globally was described subsequently estimated the projections of liver cancer incidence or mortality by 2040. Data regarding age-standardized incidence and mortality rates for liver cancer was obtained from multiple databases, including GLOBOCAN 2020, CI5 volumes I-XI, WHO mortality database, and Global Burden of Disease (GBD)-2019. Concentrating on worldwide variations, this thorough analysis offers insights into patterns of incidence and mortality based on gender and age. Our findings encompass significant indicators, including age-standardized rates (ASRs), average annual percentage change (AAPC), and future projections extending up to the year 2040. Liver cancer holds the sixth position in terms of most frequently diagnosed cancers and stands as the sixth leading cause of cancer-related deaths worldwide in 2020, accounting for 905,677 new cases and 782,000 fatalities. Additionally, liver cancer contributed to 12,528,421 age-standardized disability-adjusted life years (DALYs), with an age-standardized DALYs rate of 161.92 in 2019 worldwide. The age-specific incidence rates exhibited significant variations across different regions, showing a fivefold difference in males and females. A significant increase in incidence was observed in North Europe and Asia, while North African countries reported a higher mortality burden (ASR, 10 per 100,000) compared to developed countries. Since last few years, the incidence and mortality rates have increased and attained Annual Average Percentage Change (AAPC) incidence rate of 7.7 (95% CI 3.9-11.6) for men and the highest AAPC mortality rate of 12.2 (95% CI 9.5-15.0) for women. In 2019, Western Europe emerged as the high-risk region for DALYs related to smoking and alcohol consumption, while high-income North America carried a high risk for DALYs associated with a high body-mass index. The projected trend indicates a surge in new liver cancer incident cases, expected to rise from around 905,347 to an estimated 1,392,474 by 2040. This study described the evidence pertinent to higher incidence trends in liver cancer, particularly among both young and older adults, encompassing males and females, as well as those who are HIV-infected and HBsAg positive. A significant rise in the young population poses a significant public health concern that warrants attention from healthcare professionals to prioritize the promotion of health awareness and the development of effective cancer prevention strategies, particularly in many developing countries.

Global Incidence Trends in Very-Early-, Early-, and Late-Onset Primary Liver Cancer by Sex, Region, and Aetiology: A Study Based on Global Burden of Disease Study 2017

Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017

Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.

The Trends in Incidence of Primary Liver Cancer Caused by Specific Etiologies: Results from the Global Burden of Disease Study 2016 and Implications for Liver Cancer Prevention.

The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017

The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels

Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis

Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983–2007) and Predictions to 2030

Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019

Global Epidemiology of Early-Onset Liver Cancer Attributable to Specific Aetiologies and Risk Factors from 2010 to 2019.

Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data

Trend Analysis and Age-Period-cohort Effects on Morbidity and Mortality of Liver Cancer from 2010 to 2020 in Guangzhou, China

Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019: An age-period-cohort analysis

Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study

Global Trend of Aetiology-Based Primary Liver Cancer Incidence from 1990 to 2030: a Modelling Study

The Burden of Liver Cirrhosis and Underlying Etiologies: Results from the Global Burden of Disease Study 2019

Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990–2017: A Joinpoint and Age–Period–Cohort Analysis

Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period

Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends

Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019

Incidence trends of primary liver cancer in different geographical regions of China from 1978 to 2012 and projections to 2032: An age‐period‐cohort analysis